Has P Kasi Ramanathan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $101,453 in general payments to P Kasi Ramanathan, MD across 308 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean P Kasi Ramanathan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about P Kasi Ramanathan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

P Kasi Ramanathan, MD

Interventional Cardiology · Toledo, OHNPI 1326177536

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $79,725 of the $101,453 with a category attached, or 78.6%. Medtronic accounts for 95.2% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $68,436, more than ten times the $413 reported in 2019. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$101,453in general payments, 2019–2025

Across 308 payments — averaging $329.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$97K
Abbott$2K
Boston Scientific$1K
Edwards Lifesciences$1K
Abiomed$332
Novo Nordisk$74
plus $211 from 9 others

$81,142in research payments, 2019–2025

Across 41 payments — averaging $1979.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$77K
Abbott$4K

What the payments were for

Consulting fees$1,6502%
Speaking & faculty fees$79,72579%
Travel & lodging$9,0189%
Food & beverage$11,06011%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	209	$96,549
Abbott	34	$1,748
Boston Scientific	32	$1,351
Edwards Lifesciences	13	$1,188
Abiomed	7	$332
Novo Nordisk	1	$74
Cvrx, Inc.	1	$45
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$33
Amgen	2	$28
Novartis	1	$23
Cardiovascular Systems Inc.	1	$23
Inari Medical, Inc.	1	$20
W. L. Gore & Associates, Inc.	1	$13
Johnson & Johnson	1	$12
Biosense Webster, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$101,453 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$210,172

Medicare patients

741

Services billed

1,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	16	$11,138
JardianceEmpagliflozin	11	$6,998
Warfarin Sodium	88	$1,043
ClopidogrelClopidogrel Bisulfate	75	$696
Isosorbide Mononitrate ErIsosorbide Mononitrate	29	$283
Amlodipine Besylate	27	$167
Carvedilol	20	$149
Metoprolol Succinate	15	$107
Hydrochlorothiazide	14	$46
Furosemide	22	$40
Metoprolol Tartrate	12	$38

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Toledo

William ColyerToledo$139K
Stephanie YounesToledo$49K
Gary AnselColumbus$3.3M
John CheathamColumbus$1.4M
Carlos Sanchez SotoColumbus$1.1M
Steven YakubovColumbus$907K
Timothy HenryCincinnati$605K
Mitchell SilverColumbus$562K
John PhillipsColumbus$410K
John CorlCincinnati$390K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →